Alternatives to GeneEdit

GeneEdit is a Biotech tool: developing gene editing therapies for rare genetic diseases. Here are the 52 closest alternatives, compared on pricing, features and what real users say.

GeneEdit profile More Biotech alternatives

The 20 closest Biotech companies to GeneEdit

Editas Medicine
Not rated
A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
Visit site
Intellia Therapeutics
Not rated
A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Visit site
CRISPR Therapeutics
Not rated
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Visit site
Gene Bio Medical
Not rated
Develops advanced gene editing and cell therapy solutions for rare genetic diseases.
Visit site
Immitra Bio
Not rated
Scalable, one-time curative in-vivo gene editing therapies.
Visit site
VI Therapeutics
Not rated
VI Therapeutics is developing novel therapies for rare genetic diseases.
Visit site
Adaptive Biotechnologies
Not rated
Leveraging the adaptive immune system to diagnose and treat disease.
Visit site
BeiGene
Not rated
A global oncology company developing and commercializing innovative cancer treatments.
Visit site
Lexeo Therapeutics
3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Caris Life Sciences
Not rated
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Visit site
Guardant Health
Not rated
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Visit site
Tenaya Therapeutics
Not rated
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Visit site
Cellcolabs
Not rated
AI-powered platform for personalized cell therapy development and manufacturing.
Visit site
Regenxbio
Not rated
Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.
Visit site
Ultragenyx
Not rated
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Visit site
BioLife Solutions
Not rated
Develops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.
Visit site
Syantra
Not rated
A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Visit site
Avidity Biosciences
Not rated
Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
Visit site
Bluebird Bio
Not rated
Gene therapy company developing transformative treatments for severe genetic diseases.
Visit site
Orchard Therapeutics
Not rated
Gene therapy company developing treatments for rare inherited diseases.
Visit site

Company	Rating	Visit
Editas MedicineA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.	Not rated	Visit site
Intellia TherapeuticsA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.	Not rated	Visit site
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.	Not rated	Visit site
Gene Bio MedicalDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.	Not rated	Visit site
Immitra BioScalable, one-time curative in-vivo gene editing therapies.	Not rated	Visit site
VI TherapeuticsVI Therapeutics is developing novel therapies for rare genetic diseases.	Not rated	Visit site
Adaptive BiotechnologiesLeveraging the adaptive immune system to diagnose and treat disease.	Not rated	Visit site
BeiGeneA global oncology company developing and commercializing innovative cancer treatments.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	3.0 out of 5 (1)	Visit site
Caris Life SciencesCaris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.	Not rated	Visit site
Guardant HealthGuardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.	Not rated	Visit site
Tenaya TherapeuticsBiotechnology company developing gene therapies and regenerative medicine for heart disease.	Not rated	Visit site
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.	Not rated	Visit site
RegenxbioClinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.	Not rated	Visit site
UltragenyxBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.	Not rated	Visit site
BioLife SolutionsDevelops and markets bioproduction tools for cell and gene therapy manufacturing and distribution.	Not rated	Visit site
SyantraA precision biotechnology company developing a blood-based platform for early cancer detection and treatment.	Not rated	Visit site
Avidity BiosciencesClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.	Not rated	Visit site
Bluebird BioGene therapy company developing transformative treatments for severe genetic diseases.	Not rated	Visit site
Orchard TherapeuticsGene therapy company developing treatments for rare inherited diseases.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the GeneEdit profile.

Sponsored rows are paid and labelled. Advertise on this page